Monday, November 14, 2011

Adult Stem-Cell UPDATE: "This could be the biggest revolution in cardiovascular medicine in my lifetime.''

More great adult stem-cell news. This story is from the Telegraph:

'''The results are striking,' said Professor Roberto Bolli, one of the research leaders from the University of Louisville in the US. ''While we do not yet know why the improvement occurs, we have no doubt now that ejection fraction increased and scarring decreased.'

''If these results hold up in future studies, I believe this could be the biggest revolution in cardiovascular medicine in my lifetime.''

The ground-breaking new treatment involved extracting cardiac stem cells (CSCs) - self-renewing cells that rebuild hearts and arteries - from patients during bypass surgery.
The cells were purified and grown in the laboratory before being injected back into damaged regions of the patients' hearts four months later.

Meanwhile, the Washington Post reports more good news. Geron is abandoning the field of embryonic stem-cell research:

"The company doing the first government-approved test of embryonic stem cell therapy is discontinuing further stem cell work..."

UPDATE: Hah! The great Wesley Smith on Geron's pullout:

"This is an atom bomb of a story that will have a serious effect on the entire regenerative medical sector. And it should embarrass the critics of President Bush; the California Institute for Regenerative Medicine, which bragged about its part in funding a scientist involved in the research; and, perhaps most of all, the fawning media that have acted as press agent for both the field generally, and Geron specifically."

And we repeat one of our mantras here at A Shepherd's Voice: "Are California voters having second thoughts yet about shelling out $3 billion + for immoral & unproven embryonic stem cell research, which has yet to show a single cure, while adult stem cells are curing people left and right?"

You can read all our adult stem-cell posts here.

1 comment:

Anonymous said...

If stem cell treatments were a boxing match, Embryonic stem cell treatments would be the 500 lb Gorilla and Adult stem cell treatments would be the small, unknown underdog. Today, the Gorilla threw in the towel! What would cause the leading Embryonic stem cell Pharmaceutical company with multiple Embryonic stem cell products in development to end all of their Embryonic stem cell programs? What does it mean for patients who were waiting with desperate hope for the benefits of Embryonic stem cells?